Argentina vs Croatia: Reported rate of new cervical cancer cases
Argentina
10.64 per 100,000 women
in 2017
Croatia
9.86 per 100,000 women
in 2017
Argentina rank
12th
Croatia rank
15th
Reported rate of new cervical cancer cases over time
- Argentina
- Croatia
How they compare
Argentina currently reports 10.64 per 100,000 women against 9.86 per 100,000 women in Croatia, a difference of 0.78 per 100,000 women.
That makes Argentina's figure about 1.1 times Croatia's.
Across all 15 years both countries report, Argentina has been ahead every year.
Argentina ranks 12th and Croatia ranks 15th of 46 countries.
Argentina has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Argentina | Croatia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 13.9 per 100,000 women | 10.77 per 100,000 women | 3.13 per 100,000 women | Argentina |
| 2010s | 12.64 per 100,000 women | 10.08 per 100,000 women | 2.56 per 100,000 women | Argentina |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher reported rate of new cervical cancer cases, Argentina or Croatia?
- Argentina, at 10.64 per 100,000 women against 9.86 per 100,000 women in Croatia as of 2017.
- What is the difference in reported rate of new cervical cancer cases between Argentina and Croatia?
- 0.78 per 100,000 women, with Argentina ahead.
- How many years of comparable data are there for Argentina and Croatia?
- 15 years are reported by both, from 2003 to 2017.
- How do Argentina and Croatia rank globally for reported rate of new cervical cancer cases?
- Argentina ranks 12th and Croatia ranks 15th of 46 countries.
- Where does this data come from?
- Global Cancer Observatory (2025) – processed by Our World in Data, published as Reported rate of new cervical cancer cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported number of new cervical cancer cases per 100,000 women, based on data from cancer registries. Comparisons may be affected by differences in measurement, including screening and diagnosis.